LexDanaLexDanabeta
Inventor

Wei Chen

Inventor
Fremont, CA, US

Overview

59→
Patents
1998–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes26%
C07CAcyclic or carbocyclic compounds3%
A01KAnimal husbandry1%
H02HEmergency protective circuit arrangements1%
H10PGeneric processes or apparatus for the manufacture or treatment of devices covered by class h101%
Y02BClimate change mitigation technologies related to buildings, e.g. housing, house appliances or related end-user applications1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
C07KPeptides1%
PatentTitleYear
10,822,348Inhibitors of Bruton's tyrosine kinase and methods of their use202010,800,792Inhibitors of Bruton's tyrosine kinase and method of their use202010,717,745Inhibitors of Bruton's tyrosine kinase and method of their use202010,689,396Inhibitors of Bruton's tyrosine kinase and methods of their use202010,532,044Heteroaryl sulfonamides and CCR2/CCR9202010,206,912Heteroaryl sulfonamides and CCR2/CCR920199,862,722'Inhibitors of Bruton\'s tyrosine kinase'20189,708,326'Inhibitors of bruton\'s tyrosine kinase'20179,656,988'Inhibitors of Bruton\'s tyrosine kinase'20179,653,931'Battery protection device and operation method thereof'20179,637,487'Purinone compounds as kinase inhibitors'20179,624,224'Inhibitors of Bruton\'s tyrosine kinase'20179,580,416'Inhibitors of Bruton\'s tyrosine kinase'20179,556,182'Inhibitors of Bruton\'s tyrosine kinase'20179,546,172'Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors'20179,540,385'Pyrrolopyrimidine compounds as kinase inhibitors'20179,533,991'Inhibitors of Bruton\'s tyrosine kinase'20179,469,642'Purinone compounds as kinase inhibitors'20169,427,424'Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly'20169,382,246'Inhibitors of Bruton\'s tyrosine kinase'20169,296,740'Azaindazole compounds and methods of use'20169,278,100'Inhibitors of bruton\'s tyrosine kinase for the treatment of solid tumors'20169,273,051'Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors'20169,181,263'Inhibitors of bruton\'s tyrosine kinase'20159,138,436'Inhibitors of Bruton\'s tyrosine kinase'20159,139,591'Inhibitors of bruton\'s tyrosine kinase'20159,133,134'Inhibitors of bruton\'s tyrosine kinase'20159,096,604'Pyrrolopyrimidine compounds as kinase inhibitors'20159,079,908'Inhibitors of Bruton\'S tyrosine kinase'20159,062,058'Pyrrolopyrimidine compounds as kinase inhibitors'20159,039,925'Polishing slurry composition'20159,012,463'Inhibitors of bruton\'s tyrosine kinase'20159,001,482'Short-circuit protection circuit of light emitting diode and short-circuit protection method thereof and light emitting diode driving apparatus using the same'20158,940,750'Inhibitors of bruton\'s tyrosine kinase'20158,883,435'Inhibitors of Bruton\'s tyrosine kinase'20148,883,803'Inhibitors of Bruton\'s tyrosine kinase for the treatment of solid tumors'20148,809,273'Inhibitors of Bruton\'s tyrosine kinase'20148,784,873'Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly'20148,519,135'Heteroaryl sulfonamides and CCR2/CCR9'20138,501,724'Purinone compounds as kinase inhibitors'20138,383,630'Azaindazole compounds and methods of use'20138,377,946'Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors'20138,324,216'Substituted piperazines'20128,093,247'Heteroaryl sulfonamides and CCR2'20127,790,726'Monocyclic and bicyclic compounds and methods of use'20107,777,035'Azaindazole compounds and methods of use'20107,741,330'Pyrazolo-pyrimidine inhibitors of Bruton\'s tyrosine kinase'20107,718,662'Pyrazolo-pyrimidine inhibitors of bruton\'s tyrosine kinase'20107,622,583'Heteroaryl sulfonamides and CCR2'20097,589,199'Substituted piperazines'20097,576,106'Piperidine derivatives and methods of use'20097,576,218'4-phenylpiperdine-pyrazole CCR1 antagonists'20097,524,845'Azaindazole compounds and methods of use'20097,435,830'Bicyclic and bridged nitrogen heterocycles'20087,435,831'Bicyclic and bridged nitrogen heterocycles'20087,075,107'Semiconductor wafer and manufacturing process thereof'20066,084,792'Power converter with circuits for providing gate driving'20006,028,330'CMOS sensor having a structure to reduce white pixels'20005,767,549'SOI CMOS structure'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2020Patents assigned to CHEMOCENTRYX INC (16)· patent assignee history
2008–2020Based in Fremont, CA, US· patent location history
2010–2015Patents assigned to PHARMACYCLICS INC (13)· patent assignee history
2012–2016Patents assigned to CHEN WEI (16)· patent assignee history
2013–2016Patents assigned to LOURY DAVID J (8)· patent assignee history
2014–2016Based in Taipei, TW· patent location history
2015–2018Patents assigned to PHARMACYCLICS LLC (18)· patent assignee history
2015–2017Based in Hsinchu County, TW· patent location history
2015Based in Tainan, TW· patent location history
2020Based in Shanghai, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
PHARMACYCLICS LLC182015–2018
CHEMOCENTRYX INC162008–2020
CHEN WEIself162012–2016
PHARMACYCLICS INC132010–2015
LOURY DAVID J82013–2016
Locations
LocationPatentsSpan
Fremont, California, US452008–2020
Shanghai, CN42020
Hsinchu County, TW22015–2017
Taipei, TW22014–2016
Tainan, TW12015